Lectin-like oxidized LDL receptor 1 antibodies and methods of use

摘要

#$%^&*AU2017245335B220190404.pdf#####H:fmtinteovenNRPortblDCCFMTUl5779678_l.doex-3/10/2017 ABSTRACT The present invention relates to monoclonal antibodies binding to human lectin-like oxidized LDL (low density lipoprotein) receptor 1 (hereinafter, sometimes referred to as "LOX-1"), and pharmaceutical compositions and methods of treatment comprising the same.